Ido Goldstein

5.4k citations

75 papers · 4.2k indexed · 2 hit papers · h-index 35

Impact in

Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
Molecular Biology top 2%
- Glycosylation and Glycoproteins Research
- Epigenetics and DNA Methylation
- Genomics and Chromatin Dynamics
- RNA modifications and cancer

Papers in

Biotechnology 10
- Enzyme Production and Characterization 7
Cancer Research 17
- Cancer, Hypoxia, and Metabolism 8
- Cancer, Lipids, and Metabolism 5

Co-authors: B.B.L. Agrawal Varda Rotter Shalom Madar Lucy L. So Meital Charni‐Natan Gordon L. Hager Naomi Goldfinger Songjoon Baek
Journals: Archives of Biochemistry and Biophysics (6 papers)Carcinogenesis (3 papers)Proceedings of the National Academy of Sciences (3 papers)Trends in Endocrinology and Metabolism (3 papers)Cell Death and Differentiation (3 papers)
Partner nations: United States Israel United Kingdom

In The Last Decade

Ido Goldstein

74 papers receiving 4.0k citations

Hit Papers

align trajectories log scale

Protocol for Primary Mouse Hepatocyte Isolation 2020 · 240 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2020 STAR Protocols
1967 Biochimica et Biophysica Acta (BBA) - Protein Structure

Peers

Countries citing papers authored by Ido Goldstein

Since Specialization

Citations

This map shows the geographic impact of Ido Goldstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ido Goldstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ido Goldstein more than expected).

Fields of papers citing papers by Ido Goldstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ido Goldstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ido Goldstein. The network helps show where Ido Goldstein may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ido Goldstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ido Goldstein Line = papers co-authored together Ido Goldstein links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Transcriptional cascades during fasting amplify gluconeogenesis and instigate a secondary wave of ketogenic gene transcription Liver International ·Ahmad Alfian Fauzi, M Bin Humaid Deema, Meital Charni‐Natan, Ido Goldstein	2024	2
2	Protocol for bulk and single-nuclei chromatin accessibility quantification in mouse liver tissue STAR Protocols ·滋子長塩, J. Cottee-Meldrum, 寿太郎蓑茂, Meital Charni‐Natan, Lars Grøntved, Ido Goldstein	2023	2
3	Dynamic chromatin accessibility during nutritional iron overload reveals a BMP6-independent induction of cell cycle genes The Journal of Nutritional Biochemistry ·Claudio Meléndez, Meital Charni‐Natan, Ido Goldstein	2023	3
4	Fasting Hormones Synergistically Induce Amino Acid Catabolism Genes to Promote Gluconeogenesis Cellular and Molecular Gastroenterology and Hepatology ·滋子長塩, Bo-seon Kim, M Bin Humaid Deema, Zhiyong Feng, Meital Charni‐Natan, Ido Goldstein	2021	21
5	Steroid Receptors Reprogram FoxA1 Occupancy through Dynamic Chromatin Transitions Cell ·Erin E. Swinstead, Tina Branscombe Miranda, Ville Paakinaho, Songjoon Baek, Ido Goldstein, Mary E. Hawkins, Tatiana Karpova, David A. Ball, Davide Mazza, Luke D. Lavis, Jonathan B. Grimm, Tatsuya Morisaki, Lars Grøntved, Diego M. Presman, Gordon L. Hager	2016	221
6	Transcription factor assisted loading and enhancer dynamics dictate the hepatic fasting response Genome Research ·Ido Goldstein, Songjoon Baek, Diego M. Presman, Ville Paakinaho, Erin E. Swinstead, Gordon L. Hager	2016	80
7	TM7SF3, a novel p53-regulated homeostatic factor, attenuates cellular stress and the subsequent induction of the unfolded protein response Cell Death and Differentiation ·Roi Isaac, Ido Goldstein, Noa Furth, Herbert R. Pinnick, Πασχαλιά Γιαννακάκη, Sigalit Boura‐Halfon, Eytan Elhanany, Varda Rotter, Moshe Oren, Yehiel Zick	2016	17
8	Novel p53 target genes secreted by the liver are involved in non-cell-autonomous regulation Cell Death and Differentiation ·(unknown), Alina Molchadsky, Ido Goldstein, Hilla Solomon, C.G. Arunkumara, Naomi Goldfinger, Peirong Yang, Ziv Porat, Guillermina Lozano, Varda Rotter	2015	16
9	‘Cancer associated fibroblasts’ – more than meets the eye Trends in Molecular Medicine ·Shalom Madar, Ido Goldstein, Varda Rotter	2013	275
10	Mutant p53 Attenuates the Anti-Tumorigenic Activity of Fibroblasts-Secreted Interferon Beta PLoS ONE ·Shalom Madar, Tianhong Su, Ido Goldstein, Yan Stein, Ira Kogan-Sakin, Iris Kamer, Hilla Solomon, Elya Dekel, C.G. Arunkumara, Naomi Goldfinger, Gilgi Friedlander, Varda Rotter	2013	36
11	Various p53 mutant types differently regulate the Ras circuit to induce a cancer-related gene signature Journal of Cell Science ·Hilla Solomon, Yosef Buganim, Rachel E. Busselman, Tsevi Beatus, Majid Firouzkouhi Berenjabadi, Ira Kogan-Sakin, Shalom Madar, Ido Goldstein, Ran Brosh, Eyal Kalo, Naomi Goldfinger, Varda Rotter	2012	58
12	Mutant p53R273H attenuates the expression of phase 2 detoxifying enzymes and promotes the survival of cells with high ROS levels Journal of Cell Science ·Eyal Kalo, Ira Kogan-Sakin, Hilla Solomon, Ninan Verghese, Ke‐Wei Zhu, Yoav Shetzer, Elya Dekel, Naomi Goldfinger, Anna-Lena Falk, Perry Stambolsky, Ido Goldstein, Shalom Madar, Varda Rotter	2012	93
13	TMPRSS2/ERG Promotes Epithelial to Mesenchymal Transition through the ZEB1/ZEB2 Axis in a Prostate Cancer Model PLoS ONE ·Ferrer Arnedo C, Shalom Madar, Ira Kogan-Sakin, Iris Kamer, Ido Goldstein, Ran Brosh, Yehudit Cohen, Jasmine Jacob‐Hirsch, Marcelo Ehrlich, Shmuel A. Ben‐Sasson, Naomi Goldfinger, Ron Loewenthal, Ephraim Gazit, Varda Rotter, Raanan Berger	2011	90
14	p53 Regulates the Ras Circuit to Inhibit the Expression of a Cancer-Related Gene Signature by Various Molecular Pathways Cancer Research ·Yosef Buganim, Hilla Solomon, Yoach Rais, Joowon Jin, Ido Nachmany, Mariana Brait, Shalom Madar, Ido Goldstein, Eyal Kalo, Victor Saghana, Jeanine Awad Spirtos, Noa Rivlin, Ira Kogan, Ran Brosh, Soofi Anwar Dr. K. Durga Prasad, Naomi Goldfinger, David Sidransky, Yoel Kloog, Varda Rotter	2010	64
15	A Novel Translocation Breakpoint within the BPTF Gene Is Associated with a Pre-Malignant Phenotype PLoS ONE ·Yosef Buganim, Ido Goldstein, Doron Lipson, Michael Milyavsky, Sylvie Polak‐Charcon, D. Kubota, Hilla Solomon, Eyal Kalo, Shalom Madar, Ran Brosh, Marina Perelman, Roy Navon, Naomi Goldfinger, Iris Barshack, Zohar Yakhini, Varda Rotter	2010	49
16	Modulated expression of WFDC1 during carcinogenesis and cellular senescence Carcinogenesis ·Shalom Madar, Ran Brosh, Yosef Buganim, Osnat Ezra, Ido Goldstein, Hilla Solomon, Ira Kogan, Naomi Goldfinger, Helmut Klocker, Varda Rotter	2008	70
17	P53 in blind subterranean mole rats – loss-of-function versus gain-of-function activities on newly cloned Spalax target genes Oncogene ·Aaron Avivi, Osnat Ashur‐Fabian, Y. Kurosaki, 雅純梅木, Konstantin Adamsky, Ido Goldstein, Ninette Amariglio, G Rechavi, Eviatar Nevo	2006	39
18	Purification and characterization of Dolichos lablab lectin Glycobiology ·Hanqing Mo, Fabiola Becerra-Riera, Joseph G. Moore, Ido Goldstein	1999	21
19	Inhibition of P210BCR/ABL Expression in K562 Cells by Electroporation with an Antisense Oligonucleotide Leukemia & lymphoma ·Niti Jain, Philippe Martiat, Susheela Dhut, Tracy Chaplin, C. Dowding, K. H. Th'ng, Ido Goldstein, G Q Daley, B D Young, John M. Goldman	1990	15
20	Expression patterns of the T antigen and the cryptic T antigen in rat fetuses: detection with the lectin amaranthin. Journal of Histochemistry & Cytochemistry ·Tetsutaro Sata, Christian Zuber, M. Bastin, Ido Goldstein, Jürgen Roth	1990	14

About Ido Goldstein

Ido Goldstein is a scholar working on Biotechnology, Cancer Research, Molecular Biology, Oncology and Immunology, having authored 75 papers that have together received 4.2k indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (15 papers), Cancer-related Molecular Pathways (12 papers), Carbohydrate Chemistry and Synthesis (9 papers), Cancer, Hypoxia, and Metabolism (8 papers), Enzyme Production and Characterization (7 papers), Microbial Metabolites in Food Biotechnology (5 papers), Cancer, Lipids, and Metabolism (5 papers) and RNA modifications and cancer (5 papers). The work is most often cited by research in Cancer Research (698 citations), Molecular Biology (2.7k citations), Biotechnology (311 citations), Immunology (675 citations) and Oncology (844 citations). Ido Goldstein has collaborated with scholars based in United States, Israel and United Kingdom. Frequent co-authors include B.B.L. Agrawal, Varda Rotter, Shalom Madar, Lucy L. So, Meital Charni‐Natan, Gordon L. Hager, Naomi Goldfinger, Songjoon Baek, Ville Paakinaho and Shohei Shibata. Their work appears in journals such as Archives of Biochemistry and Biophysics, Carcinogenesis, Proceedings of the National Academy of Sciences, Trends in Endocrinology and Metabolism and Cell Death and Differentiation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact